Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; loganin inhibits the reaction [Lipopolysaccharides results in increased expression of STAT3 protein]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of STAT3 protein]; Rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]
[Lipopolysaccharides results in increased activity of JAK2 protein] which results in increased activity of STAT3 protein; Lipopolysaccharides results in increased activity of STAT3 protein
[Curcumin binds to 4-bis(2-chloroethyl)aminobenzaldehyde] inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and affects the localization of STAT3 protein]; [Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of STAT3 protein; chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]; cirsimarin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; IFNAR1 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]; IL10 protein affects the reaction [Resveratrol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]]; kaempferol 7-O-glucoside inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; Lipopolysaccharides results in increased expression of and results in increased phosphorylation of STAT3 protein; Lipopolysaccharides results in increased phosphorylation of and affects the localization of STAT3 protein; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of STAT3 protein; loganin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of STAT3 protein]; lycorine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]]; Melatonin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; morroniside inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of STAT3 protein]; praeruptorin C inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; praeruptorin E inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; Resveratrol inhibits the reaction [[Lipopolysaccharides co-treated with TLR4] results in increased phosphorylation of STAT3 protein]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]; Resveratrol promotes the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; STAT3 protein promotes the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of HMOX1 mRNA]; STAT3 protein promotes the reaction [[Lipopolysaccharides co-treated with Nicotine] results in increased expression of ZFP36 mRNA]; STAT3 protein promotes the reaction [Lipopolysaccharides results in increased expression of ZFP36 mRNA]; STAT3 protein promotes the reaction [Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; withaferin A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of STAT3 protein]
[Nicotine co-treated with Lipopolysaccharides] results in increased phosphorylation of STAT3 protein; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide promotes the reaction [daphnetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]]; daphnetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; Lipopolysaccharides results in increased phosphorylation of and results in increased activity of STAT3 protein; MIR152 mRNA affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]; REG3A protein inhibits the reaction [daphnetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT3 protein]]
